Promedior

Roche buys U.S. drugmaker Promedior for up to $1.4 billion to get lung drug
Reuters
Sat, 11/16/19 - 12:01 am
Roche
Promedior
idiopathic pulmonary fibrosis
M&A
Bristol-Myers buys rights to fibrosis drug with option to buy developer Promedior
Yahoo/AP
Mon, 08/31/15 - 09:53 am
Bristol-Myers Squibb
PRM-151
idiopathic pulmonary fibrosis
Promedior